ccd1069sk breast hf Search Results


94
ATCC ccd1069sk breast hf
Fig. 3. Southern blot for SV40 DNA in HM3 and WI38. (A) SV40 DNA extracted from the cells. (B) SV40 DNA recovered in the tissue culture medium. Lanes: 1 and 2, HM 48 h after infection; 3 and 4, HF 48 h after infection; 5 and 6, HM 72 h after infection; 7 and 8, HF 72 h after infection. Each lane represents an independent infection experiment. Almost identical results were obtained with HM2 and MRC-5 HF. HM1 and <t>CCD1069Sk</t> were not tested. The different amounts of DNA (see text) were determined by Cherenkov counting of the individual lanes. DNAs were normalized for number of Tag-positive cells.
Ccd1069sk Breast Hf, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccd1069sk+breast+hf/CCD-1069Sk/pm10954737-55-13-29
Average 94 stars, based on 1 article reviews
ccd1069sk breast hf - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Fig. 3. Southern blot for SV40 DNA in HM3 and WI38. (A) SV40 DNA extracted from the cells. (B) SV40 DNA recovered in the tissue culture medium. Lanes: 1 and 2, HM 48 h after infection; 3 and 4, HF 48 h after infection; 5 and 6, HM 72 h after infection; 7 and 8, HF 72 h after infection. Each lane represents an independent infection experiment. Almost identical results were obtained with HM2 and MRC-5 HF. HM1 and CCD1069Sk were not tested. The different amounts of DNA (see text) were determined by Cherenkov counting of the individual lanes. DNAs were normalized for number of Tag-positive cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.

doi: 10.1073/pnas.170207097

Figure Lengend Snippet: Fig. 3. Southern blot for SV40 DNA in HM3 and WI38. (A) SV40 DNA extracted from the cells. (B) SV40 DNA recovered in the tissue culture medium. Lanes: 1 and 2, HM 48 h after infection; 3 and 4, HF 48 h after infection; 5 and 6, HM 72 h after infection; 7 and 8, HF 72 h after infection. Each lane represents an independent infection experiment. Almost identical results were obtained with HM2 and MRC-5 HF. HM1 and CCD1069Sk were not tested. The different amounts of DNA (see text) were determined by Cherenkov counting of the individual lanes. DNAs were normalized for number of Tag-positive cells.

Article Snippet: 97 u no. 18 were used in our experiments at passages 17–18, and CCD1069Sk breast HF from a 70-year-old woman, which were used at passages 6–7, all from the American Type Culture Collection.

Techniques: Southern Blot, Infection

Fig. 5. (A) p53 expression in HM and HF. One hundred micrograms of total protein extracts was loaded into each lane. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Lanes: 1, HM2; 2, HM3; 3, WI38; 4, CCD1069Sk [HM1 and MRC5 (not shown) produced almost identical results]. (B) Lanes 1–6, p53 expression in untreatedHM(lanes1and2),HMtreatedwith5mMscrambledoligo(lanes3and 4), and HM treated with 5 mM antisense p53 oligo (lanes 5 and 6). Cells were harvested and lysed 48 h after the onset of treatment; 100 mg of total protein extracts was loaded per lane (each lane represent an independent experiment). Lanes 7 and 8, p53 expression in HM 5 days after treatment (and 72 h after SV40 infection) with scrambled oligos (lane 7) and antisense p53 (lane 8). (C) Lanes 1 and 2, Tag immunoprecipitation in SV40-infected HM. Lane 1, scrambled control oligo-treated HM; lane 2, antisense p53-treated HM. Tag was precipitated with the monoclonal anti-Tag AB-1 (Tag amino terminus). The membrane was probed with the monoclonal anti-Tag AB-2 (Tag carboxyl terminus), followed by mono- clonal anti-mouse IgG conjugated with horseradish peroxidase. Lanes 3 and 4, Tagyp53 coimmunoprecipitation. The membrane shown on the left was stripped ofantibodiesandprobedwiththemonoclonalanti-p53DO-1directlyconjugated with horseradish peroxidase. Lane 3, control oligo-treated HM; lane 4, antisense p53-treated HM.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.

doi: 10.1073/pnas.170207097

Figure Lengend Snippet: Fig. 5. (A) p53 expression in HM and HF. One hundred micrograms of total protein extracts was loaded into each lane. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Lanes: 1, HM2; 2, HM3; 3, WI38; 4, CCD1069Sk [HM1 and MRC5 (not shown) produced almost identical results]. (B) Lanes 1–6, p53 expression in untreatedHM(lanes1and2),HMtreatedwith5mMscrambledoligo(lanes3and 4), and HM treated with 5 mM antisense p53 oligo (lanes 5 and 6). Cells were harvested and lysed 48 h after the onset of treatment; 100 mg of total protein extracts was loaded per lane (each lane represent an independent experiment). Lanes 7 and 8, p53 expression in HM 5 days after treatment (and 72 h after SV40 infection) with scrambled oligos (lane 7) and antisense p53 (lane 8). (C) Lanes 1 and 2, Tag immunoprecipitation in SV40-infected HM. Lane 1, scrambled control oligo-treated HM; lane 2, antisense p53-treated HM. Tag was precipitated with the monoclonal anti-Tag AB-1 (Tag amino terminus). The membrane was probed with the monoclonal anti-Tag AB-2 (Tag carboxyl terminus), followed by mono- clonal anti-mouse IgG conjugated with horseradish peroxidase. Lanes 3 and 4, Tagyp53 coimmunoprecipitation. The membrane shown on the left was stripped ofantibodiesandprobedwiththemonoclonalanti-p53DO-1directlyconjugated with horseradish peroxidase. Lane 3, control oligo-treated HM; lane 4, antisense p53-treated HM.

Article Snippet: 97 u no. 18 were used in our experiments at passages 17–18, and CCD1069Sk breast HF from a 70-year-old woman, which were used at passages 6–7, all from the American Type Culture Collection.

Techniques: Expressing, Produced, Infection, Immunoprecipitation, Control, Membrane